SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZUCCATO, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.704
AS - Asia 4.809
EU - Europa 3.025
SA - Sud America 769
Continente sconosciuto - Info sul continente non disponibili 263
AF - Africa 126
OC - Oceania 29
AN - Antartide 1
Totale 16.726
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.501
SG - Singapore 1.767
CN - Cina 1.355
BR - Brasile 630
PL - Polonia 604
IT - Italia 579
VN - Vietnam 452
DE - Germania 451
HK - Hong Kong 345
UA - Ucraina 342
GB - Regno Unito 239
TR - Turchia 211
FI - Finlandia 172
FR - Francia 168
SE - Svezia 125
IN - India 123
JP - Giappone 116
RU - Federazione Russa 111
CA - Canada 104
BD - Bangladesh 98
ID - Indonesia 89
MX - Messico 67
AR - Argentina 54
NL - Olanda 54
ZA - Sudafrica 44
PK - Pakistan 33
ES - Italia 30
IQ - Iraq 27
AU - Australia 23
MY - Malesia 23
VE - Venezuela 22
BE - Belgio 21
CO - Colombia 20
EC - Ecuador 20
IR - Iran 19
CZ - Repubblica Ceca 18
EG - Egitto 18
LT - Lituania 18
UZ - Uzbekistan 17
AE - Emirati Arabi Uniti 16
PH - Filippine 15
SA - Arabia Saudita 15
AT - Austria 14
GR - Grecia 13
KE - Kenya 12
MA - Marocco 12
LV - Lettonia 11
CH - Svizzera 10
TH - Thailandia 10
IL - Israele 9
KR - Corea 9
TN - Tunisia 9
CL - Cile 8
CR - Costa Rica 7
IE - Irlanda 7
JM - Giamaica 7
JO - Giordania 7
KZ - Kazakistan 7
AZ - Azerbaigian 6
ET - Etiopia 6
LY - Libia 6
NG - Nigeria 6
NZ - Nuova Zelanda 6
PE - Perù 6
RS - Serbia 6
DZ - Algeria 5
KG - Kirghizistan 5
NP - Nepal 5
PT - Portogallo 5
RO - Romania 5
TW - Taiwan 5
HN - Honduras 4
HU - Ungheria 4
LB - Libano 4
PA - Panama 4
AL - Albania 3
AO - Angola 3
BG - Bulgaria 3
GE - Georgia 3
LK - Sri Lanka 3
PY - Paraguay 3
SV - El Salvador 3
UY - Uruguay 3
YE - Yemen 3
BB - Barbados 2
BO - Bolivia 2
EE - Estonia 2
KW - Kuwait 2
MD - Moldavia 2
PS - Palestinian Territory 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
Totale 16.449
Salva come PNG Salva come JPEG
Città #
Singapore 1.082
Ashburn 943
San Jose 608
Warsaw 600
Woodbridge 575
Beijing 495
Chandler 411
Fairfield 407
Jacksonville 382
Santa Clara 368
Hong Kong 340
Houston 318
Ann Arbor 296
Wilmington 184
New York 163
Council Bluffs 160
Ho Chi Minh City 150
Seattle 144
Ferrara 138
Los Angeles 138
Nanjing 136
Cambridge 121
Munich 117
Izmir 114
Dallas 111
Tokyo 109
Hanoi 106
Princeton 91
Lauterbourg 83
Bologna 74
Milan 71
Boardman 65
Shanghai 65
Jakarta 62
Addison 61
Bremen 55
Turku 52
São Paulo 43
Helsinki 42
Shenyang 42
Redwood City 41
San Diego 41
Hefei 40
Orem 40
Mexico City 39
Chennai 33
Toronto 33
Rio de Janeiro 31
Brooklyn 29
London 28
Chicago 26
Nanchang 26
Denver 25
Montreal 25
Buffalo 24
Jiaxing 24
Moscow 24
Tianjin 24
Dearborn 22
Falkenstein 22
Jinan 22
Atlanta 21
Changsha 21
Da Nang 21
Johannesburg 21
San Francisco 21
Haiphong 20
Hebei 20
Auburn Hills 19
Brussels 19
Frankfurt am Main 18
Ferrara di Monte Baldo 17
Phoenix 17
Stockholm 17
Belo Horizonte 16
Manchester 16
Rome 16
Tashkent 16
The Dalles 16
Dhaka 15
Falls Church 15
Poplar 15
Sydney 15
Boston 14
Brasília 14
Dong Ket 14
Guangzhou 14
Mountain View 14
Mumbai 14
Caracas 13
Curitiba 13
Leiden 13
Brno 12
Norwalk 12
Zhengzhou 12
Ankara 11
Buenos Aires 11
Baghdad 10
Charlotte 10
Kuala Lumpur 10
Totale 10.744
Salva come PNG Salva come JPEG
Nome #
A validated cellular biobank for β-thalassemia 419
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 418
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 381
TREATMENT OF BETA-THALASSEMIA PATIENTS WITH RAPAMYCIN (SIROLIMUS): FROM PRE-CLINICAL RESERCH TO A CLINICAL TRIAL 369
A validated THALAMOSS cellular biobank for β-thalassemia 342
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 301
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 301
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 282
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 249
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 237
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 234
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 230
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 227
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 218
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 217
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 215
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 212
Structure and Biological Activity of Furocoumarins 207
Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia 196
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 194
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 193
A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs 191
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 190
Cellular biosensors for the identification of fetal hemoglobin inducers 189
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 189
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 189
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 189
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 183
Development and molecular characterization of transgenic mice for beta-thalassemia 180
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 177
New synthetic isoxazole derivatives as potent inducer of fetal hemoglobin (HbF) in beta-thalassemia 176
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 176
Differentiation and apoptosis in UVA-irradiated cells treated with furocoumarin derivatives 173
Encapsulation of mithramycin into polymeric micelles by microfluidics: Regulation of the expression of the human γ-globin genes 172
Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts 169
Erythroid differentiation ability of butyric acid analogues: Identification of basal chemical structures of new inducers of foetal haemoglobin 169
Effects on erythroid differentiation of platinum(II) complexes of synthetic bile acid derivatives 168
Erythroid Induction of Chronic Myelogenous Leukemia K562 Cells Following Treatment with a Photoproduct Derived from the UV-A Irradiation of 5-Methoxypsoralen 167
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 167
Gene therapy combined with HbF induction in beta-thalassemia 163
Involvement of miRNA in erythroid differentiation 161
Gene therapy and fetal hemoglobin induction 159
Targeting the miR-221/miR-222 cluster in cancer therapy 158
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients 156
Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4+ and CD8+ T cells 155
Preparation and biological evaluation of some 1,2-O-isopropylidene-D-hexofuranose esters 151
Evidences for miRNA regulation of BCL11A gene expression 150
Recent trends in the gene therapy of β-thalassemia 148
Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study 146
Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β039-Globin Gene Editing and Induction of Fetal Hemoglobin 145
Sirolimus-mediated induction of fetal hemoglobin in beta-thalassemia: impact of the XmnI rs74482144 polymophism 144
Transcription factors (TFs) negatively regulating gamma-globin gene transcription: BCL11A is down-regulated during mithramycin induction of erythroid cells from beta-thalassemia patients 143
Down-regulation of LYAR is associated with induction of fetal hemoglobin in mithramycin-treated erythroid cells 143
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 137
Hemoglobin production in beta-thalassemia erythroid cells following alteration of biomolecular pathways regulating globin gene expression 137
Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus 136
Synthesis and cellular pharmacology studies of a series of 2-amino-3-aroyl-4-substituted thiophene derivatives 136
A β-Thalassemia Cell Biobank: Updates, Further Validation in Genetic and Therapeutic Research and Opportunities During (and After) the COVID-19 Pandemic 135
Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients 134
Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β039-thalassemia patients 134
Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts. 131
Everolimus is a potent inducer of erythroid differentation and gamma-globin gene expression in human erythroid cells 130
Inhibitory effects of SARS-CoV-2 spike protein and BNT162b2 vaccine on erythropoietin-induced globin gene expression in erythroid precursor cells from patients with β-thalassemia 129
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 129
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 129
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 129
Increased Expression of α-Hemoglobin Stabilizing Protein (AHSP) mRNA in Erythroid Precursor Cells Isolated from β-Thalassemia Patients Treated with Sirolimus (Rapamycin) 128
Therapeutic molecules for the development of a read-through approach for diseases caused by nonsense mutations 127
Development of a transgenic mouse line carrying a functional human Beta-globin gene with the IVSI-6 thalassemia mutation for in vivo screening and validation of aberrant splicing correctors 123
Generation and molecular characterization of a transgenic mouse line carrying a mutated human β°39 thalassemia β-globin gene 120
Effects of Mithramycin on BCL11A Gene Expression and on the Interaction of the BCL11A Transcriptional Complex to γ-Globin Gene Promoter Sequences 117
Production of a cellular model for the screening of inducers of fetal haemoglobin 117
Mithramycin-mediated induction of K562 cell erythroid differentiation is associated with inhibition of the mTOR-CI patway 117
Human bladder carcinoma cell line 5637 encapsulated in alginate microbeads: release of interleukins, chemokines and growth factors. 117
Mithramycin-mediated regulation of raptor gene transcription during erythroid differentiation of K562 cells 116
Thalassemia mouse model for beta-globin gene IVSI-6 mutation 114
Sex-specific transcriptional profiles identified in β-thalassemia patients 113
New Synthetic Isoxazole Derivatives Acting as Potent Inducers of Fetal Hemoglobin in Erythroid Precursor Cells Isolated from β-Thalassemic Patients 111
Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression 109
Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future Expectations 108
Readthrough of the premature stop codon beta039-thalassemia 107
null 107
Treatment of erythroid precursor cells from β‐thalassemia patients with cinchona alkaloids: Induction of fetal hemoglobin production 105
Increase of accumulationof gamma-globin mRNA in human erythroid cells treated with psoralens 104
The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies 103
null 103
Teaching during COVID-19 pandemic in practical laboratory classes of applied biochemistry and pharmacology: A validated fast and simple protocol for detection of SARS-CoV-2 Spike sequences 102
Novel biological activity of psoralens. Induction of accumulation of g-globin mRNA in human erythroid cells 98
Induction of accumulation of gamma-globin mRNA in human erythroid cells treated with psoralens 98
Induction of accumulation of gamma-globin mRNA in human erythroid cells treated with psoralens 96
Production and Characterization of K562 Cellular Clones Hyper-Expressing the Gene Encoding α-Globin: Preliminary Analysis of Biomarkers Associated with Autophagy 95
Erythroid differentiation induced by mithramycin in K562 cells is associated with inhibition of the mTOR-C1 pathway 95
THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia 94
The rs368698783 (G>A) Polymorphism Affecting LYAR Binding to the Aγ-Globin Gene Is Associated with High Fetal Hemoglobin (HbF) in β-Thalassemia Erythroid Precursor Cells Treated with HbF Inducers 91
null 87
Ultra sensitive plasmonic devices for early cancer diagnosis 86
null 85
Tobramycin is a suppressor of premature termination codons. 78
Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression 75
null 75
Totale 16.225
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 716
Totale 75.529
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022765 0 77 37 25 50 42 46 37 23 80 85 263
2022/2023958 95 91 23 125 174 129 72 82 81 8 42 36
2023/2024673 34 103 27 17 82 124 78 45 10 8 16 129
2024/20252.395 74 57 201 141 270 189 73 104 387 308 317 274
2025/20266.308 634 285 483 758 900 392 765 372 647 697 256 119
2026/2027382 218 164 0 0 0 0 0 0 0 0 0 0
Totale 16.726